Last reviewed · How we verify
NCT06033144: PRESTIO
Prevalence of Tapia's Syndrome in Weaning Unit
trial testing Diagnosis of Tapia's Syndrome in Tapia's Syndrome in 247 participants. Currently enrolling.
7 November 2025
Quick facts
| Lead sponsor | Hopital Forcilles |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 247 |
| Start date | 7 April 2023 |
| Primary completion | 7 November 2025 |
| Estimated completion | 7 April 2027 |
| Sites | 1 location across France |
Drugs / interventions tested
- Diagnosis of Tapia's Syndrome
Conditions studied
- Tapia's Syndrome — all drugs for Tapia's Syndrome →
Sponsor
Hopital Forcilles
Who can join
18 and older, any sex, with Tapia's Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tapia syndrome is a rare and poorly understood pathology. It is defined by a concomitant attack of the recurrent (branch of X) and hypoglossal (XII) nerves of peripheral or central origin. It is characterized by the paralysis of a vocal cord and the ipsilateral half of tongue. This damage is most often unilateral but it can also be bilateral. It results in dysphonia and swallowing disorders. Tapia syndrome is a rare and poorly understood pathology. To date, less than 100 cases have been described in the literature. Previous works are mainly case reports and literature reviews. No prevalence study has been performed to date. Furthermore, disagreements persist regarding the semiology. Indeed, the involvement of the soft palate is not always described.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06033144
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hopital Forcilles trials
Trials by the same sponsor.
- NCT07529210 — Effectiveness of Transcutaneous NMES as an Adjunct for Swallowing Disorders in Tracheotomized Patients · NA · not yet recruiting
- NCT06630013 — A New Ultrasound Score for Swallowing Disorders Diagnosis in Difficult-to-wean Tracheostomised Patients · recruiting
- NCT06387004 — Radiation-Related Dysphagia Development Prediction Using a Two-Step Ultrasonographic Model (R-2D-2) · recruiting
- NCT05831592 — Evaluation of the Validity and Reliability of Muscle Ultrasound in the Detection of Undernutrition · NA · completed
- NCT05479396 — The Predictive Capacity of Peripheral Muscle Function on Quality of Life Impairment at 1 Year in Subjects With Obesity · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06033144 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hopital Forcilles
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06033144.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing